Trials / Completed
CompletedNCT01887704
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
Effect of Rotational Atherectomy on Balloon-resistant Calcified Coronary Lesion the During a Long-term Follow-up Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Capital Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The optimal treatment of calcified coronary lesion remained to be elucidated. A Prospective, randomized controlled trial was perform to explore the immediate effect and long-term outcome of rotational atherectomy in patients with balloon resistant coronary lesion.
Detailed description
The inclusion criteria included patients presenting drug-resistant angina pectoris who underwent balloon resistant angioplasty. The exclusion criteria included: 1. Acute myocardial infarction within the 28 days; 2. Intolerance to aspirin, clopidogrel, contrast media, or statins; 3. Angiographic visible thrombus, or dissection; 4. Left ventricular ejection fraction (LVEF)\<35%; 5. Any type of cancer 6. Hemorrhagic stroke
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Rotablator | Rotablator, Boston Scientific, Maple Grove, MN, USA. Rotablator will be used in the Rotablator arm. |
| PROCEDURE | conventional angioplasty | Conventional angioplasty was used in both arms. |
| PROCEDURE | stenting | Stenting was implanted in both arms. |
| DEVICE | Cutting balloon | Flextome cutting balloon(Boston Scientific, Natick, MA, USA) was used in both arms. |
| DRUG | Aspirin | Aspirin will be administrated in participants in both arms. |
| DRUG | Clopidogrel | Clopidogrel will be administrated to participants in both arms. |
| DEVICE | Paclitaxel-eluting stent | Paclitaxel-eluting stent will be used in both arms. |
| DEVICE | zotarolimus-eluting stent | Zotarolimus-eluting stent will be implanted in participants in both arms. |
| DEVICE | Everolimus-eluting stent | Everolimus-eluting stent will be used in both arms. |
| DEVICE | Sirolimus-eluting stent | Sirolimus-eluting stent will be used in both arms. |
Timeline
- Start date
- 2010-01-01
- Primary completion
- 2013-05-01
- Completion
- 2013-05-01
- First posted
- 2013-06-27
- Last updated
- 2013-06-27
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01887704. Inclusion in this directory is not an endorsement.